DE60309879D1 - Verfahren zur Diagnose von Krebs - Google Patents

Verfahren zur Diagnose von Krebs

Info

Publication number
DE60309879D1
DE60309879D1 DE60309879T DE60309879T DE60309879D1 DE 60309879 D1 DE60309879 D1 DE 60309879D1 DE 60309879 T DE60309879 T DE 60309879T DE 60309879 T DE60309879 T DE 60309879T DE 60309879 D1 DE60309879 D1 DE 60309879D1
Authority
DE
Germany
Prior art keywords
diagnosis
cancer
procedure
plasm
prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60309879T
Other languages
English (en)
Inventor
Maurice Stroun
Philippe Anker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60309879D1 publication Critical patent/DE60309879D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60309879T 2003-10-29 2003-10-29 Verfahren zur Diagnose von Krebs Expired - Lifetime DE60309879D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03024757A EP1528107B1 (de) 2003-10-29 2003-10-29 Verfahren zur Diagnose von Krebs

Publications (1)

Publication Number Publication Date
DE60309879D1 true DE60309879D1 (de) 2007-01-04

Family

ID=34400483

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60309879T Expired - Lifetime DE60309879D1 (de) 2003-10-29 2003-10-29 Verfahren zur Diagnose von Krebs

Country Status (3)

Country Link
EP (1) EP1528107B1 (de)
AT (1) ATE346170T1 (de)
DE (1) DE60309879D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1997907A1 (de) 2007-06-01 2008-12-03 Friesland Brands B.V. Bifidobakterien
CN107267633A (zh) * 2017-07-20 2017-10-20 杭州更蓝生物科技有限公司 一种利用基因芯片检测结核分枝杆菌的方法
CN117660656B (zh) * 2024-02-01 2024-05-10 浙江省肿瘤医院 与胃癌预后相关的菌群标志物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250118C (en) * 1996-03-26 2009-09-29 Michael S. Kopreski Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer
EP1158055A1 (de) * 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Verfahren zur Diagnose von Krebs
US6753137B2 (en) * 2001-01-31 2004-06-22 The Chinese University Of Hong Kong Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma

Also Published As

Publication number Publication date
EP1528107B1 (de) 2006-11-22
EP1528107A1 (de) 2005-05-04
ATE346170T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
WO2006128192A3 (en) Use of free circulating dna for diagnosis, prognosis, and treatment of cancer
ATE275642T1 (de) Verfahren zur diagnose von krebs
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
DE60237531D1 (de) Verfahren zum trennen von seltenen zellen von fluidproben
BRPI0607508B8 (pt) método para detecção e/ou classificação de distúrbios proliferativos celulares colorretais ou hepatocelulares, e uso do mesmo
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE429495T1 (de) Nukleinsäuren für die apoptose von krebszellen
ATE352641T1 (de) Zirkulierendes epstein-barr virus dna im serum der patienten mit gastrischem krebs
HK1086331A1 (en) Compounds and methods for detection of carcinomas and their precursor lesions
MX2007008984A (es) Marcadores de cancer y metodos de deteccion.
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE50104561D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente
DE602005023329D1 (de) VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
DE60309879D1 (de) Verfahren zur Diagnose von Krebs
ATE429440T1 (de) Formen prostataspezifischer antigene und verfahren zu deren nachweis
WO2003099107A3 (en) Methods and kits for the detection of renal cell carcinoma in a biological fluid of a patient
DE60329224D1 (de) Verfahren zur Bestimmung von zirkulierender DNS in Plasma und zum Nachweis von Krebs
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Legal Events

Date Code Title Description
8332 No legal effect for de